Archive for the ‘misconduct investigations’ Category
A late researcher in Italy who has already been blamed for image manipulation in a PLOS ONE retraction notice has had two more papers retracted, both from Free Radical Biology and Medicine.
The European Heart Journal has issued an expression of concern for a
2014 2001 paper by Don Poldermans, the Dutch heart researcher who stepped down from his post at Erasmus University after being accused of misconduct.
The article, “Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery,” appeared in July and reported data from the DECREASE trial. Poldermans, who left Erasmus in 2011, has acknowledged failing to receive informed consent from some patients in one phase of the DECREASE study but denied having fabricated results.
Want bogus data, million-dollar fraud allegations and a scientist on the lam? We give you Alain Malafosse.
The British Journal of Psychiatry has retracted a June 2013 paper by Malafosse and his colleagues on the genetics of bipolar disorder in children because Malafosse allegedly fabricated key data in the study.
The article, “Childhood maltreatment and methylation of the glucocorticoid receptor gene NR3C1 in bipolar disorder,” purported to find that people with bipolar disorder who had experienced more, and more severe, abuse early in life were more likely to show epigenetic changes. According to the abstract:
The Danish Committees on Scientific Dishonesty (DCSD, Danish acronym UVVU) has partially reversed a December 2013 finding of misconduct against a scientist in Denmark, but has upheld most of its ruling.
Bente Klarlund Pedersen, whose case was tied up with that of Milena Penkowa, another scientist in Denmark found guilty of misconduct, committed misconduct in four of 12 articles examined, not six, the DCSD said in a statement last week.
Courtesy of The Australian, we have an update on a story we first covered in late 2012.
As we reported then:
A contested retraction in Stem Cells and Development has left the Queensland University of Technology (QUT) graduate student who fought for it in limbo, uncertain if he will earn his PhD. And many of those who didn’t want the paper retracted have a significant financial interest in a company whose work was promoted by the research — despite any lack of disclosure in the now-retracted paper.
Immunology paper retracted for inappropriate presentation but “no evidence of intentional misconduct”
However, the original data are now unavailable, according to the notice, so there’s no way to know if the paper’s conclusions are sound.
The Japanese endocrinology researcher Shigeaki Kato, with at least 25 retractions to his name, is alleged to have been the ringleader of a scheme to cover up other research misconduct at the University of Tokyo, his former employer, which investigated the activity.